Clinical Trial Update: Liraglutide Improve Cognitive Function in Patients With Type 2 Diabetes Mellitus [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating liraglutide for cognitive function improvement in patients with Type 2 diabetes mellitus has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• liraglutide (liraglutide)

Snippet

Sponsor: Third Military Medical University | Conditions: Type 2 Diabetes Mellitus | Phase 3 | Status: COMPLETED